Basit öğe kaydını göster

Tropisetron (Navoban (R)) in the control of nausea and vomiting induced by combined cancer chemotherapy in children

dc.contributor.authorYildiz, I
dc.contributor.authorCelkan, T
dc.contributor.authorYuksel, L
dc.contributor.authorApak, H
dc.contributor.authorOzkan, A
dc.date.accessioned2021-03-03T08:02:40Z
dc.date.available2021-03-03T08:02:40Z
dc.date.issued1999
dc.identifier.citationOzkan A., Yildiz I., Yuksel L., Apak H., Celkan T., "Tropisetron (Navoban (R)) in the control of nausea and vomiting induced by combined cancer chemotherapy in children", JAPANESE JOURNAL OF CLINICAL ONCOLOGY, cilt.29, sa.2, ss.92-95, 1999
dc.identifier.issn0368-2811
dc.identifier.otherav_1559d9d6-46ee-43d7-969e-a778d46246d4
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/19720
dc.identifier.urihttps://doi.org/10.1093/jjco/29.2.92
dc.description.abstractBackground: We aimed to assess the potency and efficacy of tropisetron, a 5-HT3 receptor antagonist, in the prevention of nausea and emesis observed in the pediatric patient population taking various chemotherapy protocols.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleTropisetron (Navoban (R)) in the control of nausea and vomiting induced by combined cancer chemotherapy in children
dc.typeMakale
dc.relation.journalJAPANESE JOURNAL OF CLINICAL ONCOLOGY
dc.contributor.department, ,
dc.identifier.volume29
dc.identifier.issue2
dc.identifier.startpage92
dc.identifier.endpage95
dc.contributor.firstauthorID122699


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster